{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:24:50Z","timestamp":1784690690698,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY 015181"],"award-info":[{"award-number":["EY 015181"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1002\/jps.23127","type":"journal-article","created":{"date-parts":[[2012,4,3]],"date-time":"2012-04-03T14:29:08Z","timestamp":1333463348000},"page":"2353-2363","source":"Crossref","is-referenced-by-count":20,"title":["MRI Study of Subconjunctival and Intravitreal Injections"],"prefix":"10.1016","volume":"101","author":[{"given":"S. Kevin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-huei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1002\/jps.23127_bb0010","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/nbm.1230","article-title":"MRI in ocular drug delivery","volume":"21","author":"Li","year":"2008","journal-title":"NMR Biomed"},{"issue":"8","key":"10.1002\/jps.23127_bb0015","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1167\/iovs.04-0091","article-title":"Controlled drug release from an ocular implant: An evaluation using dynamic three-dimensional magnetic resonance imaging","volume":"45","author":"Kim","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1002\/jps.23127_bb0020","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11095-007-9408-z","article-title":"Drug elimination kinetics following subconjunctival injection using dynamic contrast-enhanced magnetic resonance imaging","volume":"25","author":"Kim","year":"2008","journal-title":"Pharm Res"},{"issue":"4","key":"10.1002\/jps.23127_bb0025","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1167\/iovs.03-0821","article-title":"Magnetic resonance imaging study of current and ion delivery into the eye during transscleral and transcorneal iontophoresis","volume":"45","author":"Li","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1002\/jps.23127_bb0030","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s11095-004-7669-3","article-title":"Assessment of subconjunctival delivery with model ionic permeants and magnetic resonance imaging","volume":"21","author":"Li","year":"2004","journal-title":"Pharm Res"},{"issue":"1\u20132","key":"10.1002\/jps.23127_bb0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijpharm.2006.11.001","article-title":"Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging","volume":"335","author":"Molokhia","year":"2007","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1002\/jps.23127_bb0040","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/jps.21003","article-title":"Examination of barriers and barrier alteration in transscleral iontophoresis","volume":"97","author":"Molokhia","year":"2008","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1002\/jps.23127_bb0045","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.exer.2008.10.010","article-title":"Transscleral iontophoretic and intravitreal delivery of a macromolecule: Study of ocular distribution in vivo and postmortem with MRI","volume":"88","author":"Molokhia","year":"2009","journal-title":"Exp Eye Res"},{"issue":"12","key":"10.1002\/jps.23127_bb0050","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1007\/s11095-011-0507-5","article-title":"Ocular pharmacokinetic study using T1 mapping and Gd-chelate-labeled polymers","volume":"28","author":"Shi","year":"2011","journal-title":"Pharm Res"},{"issue":"2","key":"10.1002\/jps.23127_bb0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.iae.0000242853.80913.63","article-title":"Posterior juxtascleral injection of anecortave acetate: Magnetic resonance and echographic imaging and localization in rabbit eyes","volume":"27","author":"Jockovich","year":"2007","journal-title":"Retina"},{"issue":"2","key":"10.1002\/jps.23127_bb0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10439-005-8974-7","article-title":"Study of ocular transport of drugs released from an intravitreal implant using magnetic resonance imaging","volume":"33","author":"Kim","year":"2005","journal-title":"Ann Biomed Eng"},{"issue":"7","key":"10.1002\/jps.23127_bb0065","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0730-725X(94)91232-L","article-title":"Visualization of subtle contrast-related intensity changes using temporal correlation","volume":"12","author":"Wood","year":"1994","journal-title":"Magn Reson Imaging"},{"key":"10.1002\/jps.23127_bb0070","first-page":"4990","article-title":"A field comparison of r1 and r2* relaxivities of Gd-DTPA in aqueous solution and whole blood: 3T versus 7T","volume":"18","author":"Kalavagunta","year":"2010","journal-title":"Proc Int Soc Magn Reson Med"},{"issue":"Suppl 1","key":"10.1002\/jps.23127_bb0075","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1016\/S1076-6332(98)80106-2","article-title":"Blood-pool contrast agents for MRI: A critical evaluation","volume":"5","author":"Koenig","year":"1998","journal-title":"Acad Radiol"},{"issue":"3","key":"10.1002\/jps.23127_bb0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.rli.0000197668.44926.f7","article-title":"Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla","volume":"41","author":"Pintaske","year":"2006","journal-title":"Invest Radiol"},{"issue":"8","key":"10.1002\/jps.23127_bb0085","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1167\/iovs.10-6233","article-title":"Sclera-choroid-RPE transport of eight beta-blockers in human, bovine, porcine, rabbit, and rat models","volume":"52","author":"Kadam","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1002\/jps.23127_bb0090","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s11095-010-0237-0","article-title":"Influence of permeant lipophilicity on permeation across human sclera","volume":"27","author":"Wen","year":"2010","journal-title":"Pharm Res"},{"issue":"3","key":"10.1002\/jps.23127_bb0095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.exer.2005.08.007","article-title":"A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide","volume":"82","author":"Robinson","year":"2006","journal-title":"Exp Eye Res"},{"issue":"3","key":"10.1002\/jps.23127_bb0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000209665","article-title":"Novel drug delivery systems for retinal diseases. A review","volume":"41","author":"Lee","year":"2009","journal-title":"Ophthalmic Res"},{"issue":"10","key":"10.1002\/jps.23127_bb0105","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1167\/iovs.10-5337","article-title":"Evaluation of clearance mechanisms with transscleral drug delivery","volume":"51","author":"Lee","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1002\/jps.23127_bb0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0002-9394(14)70131-X","article-title":"Peribulbar corticosteroid injection: Vitreal and serum concentrations after dexamethasone disodium phosphate injection","volume":"123","author":"Weijtens","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1002\/jps.23127_bb0115","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/bjo.54.9.615","article-title":"Systemic absorption of Soframycin after subconjunctival injection","volume":"54","author":"Bron","year":"1970","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1002\/jps.23127_bb0120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/10807680152729257","article-title":"Drug delivery to the posterior segment of the eye: Some insights on the penetration pathways after subconjunctival injection","volume":"17","author":"Lee","year":"2001","journal-title":"J Ocul Pharmacol Ther"},{"issue":"Pt 6","key":"10.1002\/jps.23127_bb0125","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/eye.1999.214","article-title":"The incidence of systemic side-effects following subconjunctival Mydricaine no. 1 injection","volume":"13","author":"Steel","year":"1999","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1002\/jps.23127_bb0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000266253","article-title":"Intraocular penetration kinetics of prednisolone after subconjunctival injection in rabbits","volume":"20","author":"Tsuji","year":"1988","journal-title":"Ophthalmic Res"},{"issue":"4","key":"10.1002\/jps.23127_bb0135","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/108076801753162807","article-title":"Review: Practical issues in intravitreal drug delivery","volume":"17","author":"Maurice","year":"2001","journal-title":"J Ocul Pharmacol Ther"},{"issue":"11","key":"10.1002\/jps.23127_bb0140","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1002\/jps.23127_bb0145","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/jmri.22719","article-title":"Manganese-enhanced MRI reveals multiple cellular and vascular layers in normal and degenerated retinas","volume":"34","author":"Nair","year":"2011","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"10.1002\/jps.23127_bb0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jmri.21606","article-title":"Combination of Mn2+-enhanced and diffusion tensor MR imaging gives complementary information about injury and regeneration in the adult rat optic nerve","volume":"29","author":"Thuen","year":"2009","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"10.1002\/jps.23127_bb0155","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mrm.1209","article-title":"Mapping of retinal projections in the living rat using high-resolution 3D gradient-echo MRI with Mn2+-induced contrast","volume":"46","author":"Watanabe","year":"2001","journal-title":"Magn Reson Med"},{"issue":"2","key":"10.1002\/jps.23127_bb0160","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1167\/iovs.06-0670","article-title":"Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging","volume":"48","author":"Kim","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1002\/jps.23127_bb0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.exer.2010.05.022","article-title":"Ocular pharmacokinetic study of a corticosteroid by 19F MR","volume":"91","author":"Liu","year":"2010","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1002\/jps.23127_bb0170","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1148\/radiol.2422060245","article-title":"Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: In vitro study","volume":"242","author":"Heinrich","year":"2007","journal-title":"Radiology"},{"issue":"4","key":"10.1002\/jps.23127_bb0175","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0730-725X(90)90055-7","article-title":"The relationship between thermodynamics and the toxicity of gadolinium complexes","volume":"8","author":"Cacheris","year":"1990","journal-title":"Magn Reson Imaging"},{"issue":"5","key":"10.1002\/jps.23127_bb0180","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/jmri.21135","article-title":"Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis","volume":"26","author":"Ersoy","year":"2007","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"10.1002\/jps.23127_bb0185","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/js9504604","article-title":"Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells","volume":"85","author":"Tomita","year":"1996","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1002\/jps.23127_bb0190","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1167\/iovs.03-1381","article-title":"Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats","volume":"45","author":"Berkowitz","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1002\/jps.23127_bb0195","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/RLI.0b013e3181ee5a9e","article-title":"High relaxivity magnetic resonance imaging contrast agents. Part 1. Impact of single donor atom substitution on relaxivity of serum albumin-bound gadolinium complexes","volume":"45","author":"Dumas","year":"2010","journal-title":"Invest Radiol"},{"issue":"39","key":"10.1002\/jps.23127_bb0200","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1021\/ja961743g","article-title":"Structural and dynamic parameters obtained from 17O NMR, EPR and NMRD studies of monomeric and dimeric Gd3+ complexes of interest in magnetic resonance imaging: An integrated and theoretically self-consistent approach","volume":"118","author":"Powell","year":"1996","journal-title":"J Am Chem Soc"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915315185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915315185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T01:04:11Z","timestamp":1638925451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915315185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0022354915315185"],"URL":"https:\/\/doi.org\/10.1002\/jps.23127","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}